Year-over-year earnings per share growth for the last twelve months: Psychemedics Corp. (PMD)

Psychemedics - graphic logo of issuer PMD

The quarterly growth rate of net income per share for Psychemedics (PMD) reflects a trend where the current parameter equals 74.90. Stability is driven by an automated Californian molecular analysis center, while unique hair diagnostics patents and government contracts guarantee the resilience of its positions. Independence from macroeconomic factors and the demand for medical developments transform the asset into a reliable defensive tool.

Psychemedics Corp. (PMD) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 12/21/2024
Flagship merchandise of Psychemedics Inc

Fundamental multiplier dynamics determine an asset's investment potential, where a steady increase in yield confirms the effectiveness of capital management. By analyzing quarterly net income growth per share, an investor tracks the percentage change in EPS between reports, which for Psychemedics (PMD) reflects the success of commercial scaling for hair analysis systems in the B2B sector and expansion within the medical research market.

Analysis of competing companies

Agilent (A) - Year-over-year earnings per share growth for the last twelve months|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity, Inc. (RVTY)|Year-over-year net earnings per share change for the last twelve months bio-rad.com|Anbio - Year-over-year net earnings per share growth for the last 12 months|Sotera Health Corp (SHC) - Earnings per share growth in annualized terms for the last twelve months|QuidelOrtho Corp - Quarterly EPS earnings growth|OPKO Health Corp. (OPK) - Year-over-year net earnings per share growth for the last 12 months|CDNA: Quarterly EPS earnings growth|maravai.com - Year-over-year earnings per one share growth for the last 12 months|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Standard BioTools Inc LAB|Year-over-year earnings per share growth for the last twelve months Cytek Bio (CTKB)|Year-over-year net earnings per share growth for the last 12 months OraSure Corp OSUR|Quarterly EPS earnings growth XGN (Exagen)|mdxhealth.com (MDXH) - Earnings per share growth in annualized terms for the last twelve months|Lucid Diagnostics - Quarterly EPS earnings growth|PRE (Prenetics Global) - Year-over-year earnings per share growth for the last 12 months|IMDX: Quarterly EPS earnings growth|TRIB - Year-over-year net earnings per share change for the last twelve months|PRPH (ProPhase Labs, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ainos.com (AIMD)|Year-over-year earnings per share growth for the last twelve months Co-Diagnostics (CODX)|Year-over-year net earnings per share change for the last twelve months Heart Test Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Biomerica, Inc BMRA|CDIO (Cardio Diagnostics Holdings Inc.) - Year-over-year net earnings per share trend for the last twelve months|ONCO - Year-over-year earnings per share growth for the last twelve months|viraxbiolabs.com (VRAX) - Year-over-year net earnings per share growth for the last 12 months|BJDX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months AWH|Year-over-year earnings per share growth for the last twelve months Accelerate Diagnostics, Inc|Year-over-year net earnings per share growth for the last 12 months CENTOGENE N.V. (CNTG)|Quarterly EPS earnings growth ENZ|FRES - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth GENE (Genetic Technologies Limited)|ME: Year-over-year earnings per share growth for the last 12 months